CRT Capital Initiates Coverage on St. Jude Medical (STJ)
Analysts at CRT Capital assumed coverage on shares of St. Jude Medical (NYSE:STJ) in a research report issued to clients and investors on Monday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $80.00 price target on the stock. CRT Capital’s price target would suggest a potential upside of 13.77% from the stock’s previous close.
The analysts wrote, “buy”
Shares of St. Jude Medical (NYSE:STJ) opened at 70.32 on Monday. St. Jude Medical has a 52-week low of $46.75 and a 52-week high of $71.90. The stock has a 50-day moving average of $66.75 and a 200-day moving average of $64.96. The company has a market cap of $19.987 billion and a P/E ratio of 27.28.
St. Jude Medical (NYSE:STJ) last announced its earnings results on Wednesday, April 16th. The company reported $0.96 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.95 by $0.01. The company had revenue of $1.36 million for the quarter, compared to the consensus estimate of $1.36 million. During the same quarter last year, the company posted $0.92 earnings per share. St. Jude Medical’s revenue was up 1.9% compared to the same quarter last year. On average, analysts predict that St. Jude Medical will post $3.99 earnings per share for the current fiscal year.
A number of other firms have also recently commented on STJ. Analysts at Zacks reiterated a “neutral” rating on shares of St. Jude Medical in a research note on Monday. They now have a $74.00 price target on the stock. Separately, analysts at Wells Fargo & Co. reiterated an “average” rating on shares of St. Jude Medical in a research note on Thursday, May 29th. Finally, analysts at Morgan Stanley reiterated an “overweight” rating on shares of St. Jude Medical in a research note on Friday, May 9th. They now have a $75.00 price target on the stock. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and eleven have given a buy rating to the stock. St. Jude Medical presently has an average rating of “Hold” and an average price target of $66.88.
St. Jude Medical, Inc (NYSE:STJ) develops, manufactures and distributes cardiovascular medical devices.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.